Efficacy of risperidone consta for improving ability to benefit from skills training in schizophrenia.

Trial Profile

Efficacy of risperidone consta for improving ability to benefit from skills training in schizophrenia.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Antipsychotics; Risperidone
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Mar 2009 Trial phase changed from II to III as reported by ClinicalTrials.gov.
    • 01 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top